Similar Articles
1341 Role of innate immunity in the development of hepatocellular carcinoma
1342 Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation
1343 Striking similarities in genetic aberrations between a rectal tumor and its lung recurrence
1344 Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update
1345 Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: Is ablative margin of more than 1 cm justified?
1346 Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: The utility of conventional MR imaging
1347 Massive upper gastrointestinal hemorrhage due to invasive hepatocellular carcinoma and hepato-gastric fistula
1348 Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: A meta-analysis
1349 Surveillance for hepatocellular carcinoma in chronic liver disease: Evidence and controversies
1350 Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA